Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 122 participants.
Also called NCT07550296
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 122 participants
- Registry
-
NCT07550296
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07550296. Randomized; single masking; primary purpose treatment. Start 2026-05-06 (actual); primary completion 2027-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- prourokinase
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct07550296- Content hash
b8f62dced5bdfeb7d90cf994d3e70c275e66f1391f6799177088f66afe9a6231